Insight on Pharmaceuticals and Healthcare in North America

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

Results are sorted by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Strategies for Comparative Efficacy Trials

Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.

Published By Datamonitor
23 Aug 2012 $2800
Buy
Report
Report

Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales

This report analyzes pharma-payer deals as a brand lifecycle management strategy and includes an overview of the strategy with key success drivers and resistors and successful and unsuccessful case studies of such deals.

Published By Datamonitor
16 Aug 2012 $1520
Buy
Report
Report

Product Profiles: Non-Insulin Antidiabetics – Options abound as the SGLT-2 class prepares for market entry

Datamonitor profiles leading, currently marketed non-insulin brands as well as pipeline products launching in the near future. Coverage: the US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
14 Aug 2012 $4800
Buy
Report
Report

Market and Product Forecasts: HER2-Negative/Hormone Receptor-Positive Breast Cancer - Patent expiries and novel drugs shape the market in the next decade

This report and accompanying deliverable provides forecasts for HER2-/HR+ breast cancer drugs in the seven major markets from 2011-20. Including in-depth analysis of the market in individual countries and molecule dynamics of the key therapies.

Published By Datamonitor
19 Jul 2012 $6400
Buy
Report
Report

In Vitro Diagnostics M&A and Deal Trends

This report provides an analysis of strategies and trends employed by companies operating in the in vitro diagnostics (IVDs) market in order to drive revenue growth.

Published By Datamonitor
17 Jul 2012 $2800
Buy
Report
Report

Prescribing Influences: Schizophrenia – Plethora of antipsychotics fail to address negative symptoms

This report analyzes the unmet needs of schizophrenia treatment and the attributes of drugs that influence the prescribing decisions made by physicians across the seven major markets.

Published By Datamonitor
26 Jun 2012 $2800
Buy
Report
Report

Market and Product Forecasts: Non-Insulin Antidiabetics – Incretin mimetics face off in type 2 diabetes

Datamonitor patient-based forecast of leading non-insulin brands and pipeline products for 2011 to 2020. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
29 May 2012 $6400
Buy
Report
Report

R&D Trends 2012

Analysis of strategies and trends being employed by the leading pharmaceutical companies in order to overcome the ongoing R&D challenges, in addition to examining clinical pipelines and strategies to source new drugs.

Published By Datamonitor
14 May 2012 $2800
Buy
Report
Report

Case Study: Autism Spectrum Disorders – Public awareness and physician detailing will drive market growth

This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision-making by providing actionable recommendations in the current treatment pathway.

Published By Datamonitor
16 Apr 2012 $1520
Buy
Report
Report

Market and Product Forecasts: HIV – Rising prevalence and novel STRs boost sales in the US and Europe

This report provides an overview of current HIV treatments in the US and five major EU markets (France, Germany, Italy, Spain, and the UK), supported by a large physician survey, key opinion leader insight, and a patient-based forecast.

Published By Datamonitor
24 Feb 2012 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

No help is available.